Objectives: To determine if atrophy rates were higher for entorhinal cortex (ERC) than for
hippocampus in Alzheimer disease (AD), to determine the relationship between …

Objectives: To explore the atrophy rate of entorhinal cortex (ERC) in AD and normal aging
and assess the value of rate measurement of ERC atrophy for classifying subjects with AD …

Background: MRI measures of the entorhinal cortex and the hippocampus have been used
to predict which nondemented individuals with memory problems will progress to meet …

Objective: MRI-based measurements of hippocampal atrophy are a sensitive indicator of the
early pathologic degeneration of the medial temporal lobe in AD. However, AD pathology …

Objective: To determine if baseline entorhinal and hippocampal volumes and their rate of
atrophy could predict the risk of incident Alzheimer disease (AD). Methods: The authors …

Hippocampal atrophy is a marker of Alzheimer disease (AD). It remains unclear whether this
holds true for younger patients as well. Hippocampal volume was measured on MRI scans …

Objective: To test the hypothesis that entorhinal cortex (EC) volume decreases at a slower
rate than the hippocampal (HC) volume in healthy adults, and to examine whether the rate of …

Using quantitative structural MRI protocols, we examined the effects of age on alterations in
entorhinal cortex (EC) volume. The left EC was found to be smaller than the right in both …

Objectives To determine whether nondemented subjects with pathological evidence of
preclinical Alzheimer disease (AD) demonstrate neuronal loss in the entorhinal cortex and …

Objective: To describe atrophic changes of the hippocampus and entorhinal cortex in
frontotemporal dementia (FTD) and compare them with those of AD. Background: The …